| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |